Document:

exv10w59

Exhibit 10.59

MEDQUIST HOLDINGS INC.

RESTRICTED STOCK AWARD AGREEMENT

          THIS RESTRICTED STOCK AWARD AGREEMENT (this “Award” or “Agreement”) is made by
and between MedQuist Holdings Inc. (the “Company”) and Juergen Fritsch (the
“Grantee”) as of this 18th day of August, 2011 (the “Effective Date”).

          WHEREAS, pursuant to that certain Agreement and Plan of Merger and Reorganization, dated July
11, 2011, by and among the Company, Multimodal Technologies, Inc., a Pennsylvania corporation
(“Multimodal”) and certain other parties thereto, the Company acquired Multimodal (the
“Transaction”); and

          WHEREAS, in order to induce the Grantee to join the employ of the Company in connection with
the Transaction, and to further align the Grantee’s financial interests with those of the Company’s
stockholders, the Board approved this Award of shares of common stock of the Company subject to the
restrictions and on the terms and conditions contained in this Agreement (the “Restricted
Stock”); and

          WHEREAS, this Award of Restricted Stock is intended to constitute a non-plan based “inducement
grant,” as described in the Nasdaq Listing Rule 5635(c)(4).

          NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the
parties, intending to be legally bound hereby, agree as follows:

     1. Award of Restricted Shares.

          (a) The Company hereby awards the Grantee 78,358 shares of Restricted Stock (the
“Restricted Shares”).

          (b) The Company maintains the MedQuist Holdings Inc. 2010 Equity Incentive Plan (the
“Plan”), which provides the general terms and restrictions for certain equity incentive
awards to the Company’s employees, directors, consultants, and other individuals who provide
services to the Company. This Award of Restricted Stock is not awarded pursuant to the Plan, but
rather is intended to constitute a non-plan based “inducement grant,” as described in Nasdaq
Listing Rule 5635(c)(4). Nonetheless, the terms and provisions of the Plan relating to restricted
stock (including, without limitation, Section 9 of the Plan) are hereby incorporated into this
Agreement by this reference, as though fully set forth herein, as if the Restricted Shares were
granted pursuant to the Plan. Unless the context herein otherwise requires, the terms defined in
the Plan shall have the same meanings herein.

     2. Vesting of Restricted Shares. The Restricted Shares are subject to forfeiture to
the Company until they become vested and non-forfeitable in accordance with this Section 2. While
subject to forfeiture, the Restricted Shares may not be sold, pledged, assigned, otherwise
encumbered or transferred in any manner, whether voluntarily or involuntarily by the operation of
law, except to (i) an immediate family member or (ii) a trust or other estate-planning vehicle
(collectively, the “Permitted Transferees”), so long as any such Permitted Transferee, as a
condition to such transfer, agrees in writing to be bound by the terms of this Agreement with
respect to the Restricted Shares.

          (a) 100% of the Restricted Shares subject hereto shall become vested and non-forfeitable on
the third anniversary of the Effective Date, provided the Grantee remains in continuous service
with the Company through such date.

 

 

          (b) Upon cessation of the Service Relationship (hereinafter defined), any Restricted Shares
which then remain forfeitable (determined after application of Section 2(c), below) will
immediately and automatically, without any action on the part of the Company, be forfeited, and the
Grantee will have no further rights with respect to those shares.

          (c) If the Service Relationship (as defined below) terminates due to the Grantee’s
death, or if a Change in Control (as defined below) occurs during the Service Relationship, any
otherwise unvested Restricted Shares will then become vested and non-forfeitable. Similarly, if
the Service Relationship ceases due to a termination by the Company without “Cause”, due to
the Grantee’s “Disability” or due to a resignation by the Grantee with “Good
Reason” (each as defined in that certain Employment Agreement between the Grantee and the
Company dated on or about the closing date of the Transaction (the “Employment Agreement”)), and
the Grantee executes a release of claims in the form and manner described in Section 7(c)(iii) of
the Employment Agreement within the timeframe established in the Employment Agreement, any
otherwise unvested Restricted Shares will become vested and non-forfeitable when such release
becomes irrevocable.

          (d) For purposes of this Agreement, “Service Relationship” means the Grantee’s
employment or service with the Company or its parent or any subsidiary or Affiliate, whether in the
capacity of an employee, director or a consultant. Unless otherwise determined by the Board, the
Grantee’s Service Relationship shall not be deemed to have terminated merely because of a change in
the capacity in which the Grantee renders service to the Company or a transfer between locations of
the Company, its parent or any subsidiary or Affiliate or a transfer between the Company, its
parent, or any subsidiary or Affiliate, provided that there is no interruption or other termination
of the Service Relationship. Subject to the foregoing and the following sentence, the Company, in
its discretion, shall determine whether the Grantee’s Service Relationship has terminated and the
effective date of such termination. The following events shall not be deemed a termination of the
Service Relationship:

               i. an approved leave of absence for sickness, or for any other purpose approved by
the Board; provided, however, that if any such leave exceeds ninety (90) days, then
on the ninety-first (91st) day of such leave, the Grantee’s Service Relationship shall
be deemed to have terminated unless the Grantee’s right to return to service is guaranteed either
by a statute or by contract; and

               ii. notwithstanding the foregoing, unless otherwise designated by the Board or
required by law, a leave of absence shall not be treated as service for purposes of determining
vesting under this Agreement.

          (e) For purposes of this Agreement, the term “Change in Control” means the occurrence
of any one of the following:

               i. Any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities
Exchange Act of 1934, as amended), other than (a) a trustee or other fiduciary holding securities
under an employee benefit plan of the Company or any of its subsidiaries, (b) a corporation owned
directly or indirectly by the shareholders of the Company in substantially the same proportions as
their ownership of stock of the Company, or (c) Siris Capital Group, LLC or any of its affiliates
is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said Exchange Act), directly
or indirectly, of securities of the Company by reason of having acquired such securities during the
twelve month period ending on the date of the most recent acquisition (not including any securities
acquired directly from the Company) representing 50% or more of the total combined voting power of
the Company’s then outstanding voting securities (the “Voting Stock”);

-2-

 

               ii. the majority of members of the Board is replaced during any 12-month period by
directors whose appointment or election is not endorsed by a majority of the members of the Board
before the date of the appointment or election; or

               iii. consummation of a reorganization, merger or consolidation resulting in a change
described in (i) or (ii) of this definition, or the sale or other disposition of all or
substantially all of the assets of the Company involving 50% or more of the total gross fair market
value of all of the assets of the Company immediately before such sale of assets (a “Business
Combination”), in each case, unless all or substantially all of the individuals and entities who
were the beneficial owners, respectively, of the Voting Stock immediately prior to such Business
Combination beneficially own, directly or indirectly, more than 50% of the total voting power
represented by the voting securities entitled to vote generally in the election of directors of the
corporation resulting from the Business Combination in substantially the same proportions as their
ownership, immediately prior to the Business Combination of the Voting Stock of the Company.

     3. Issuance of Shares.

          (a) The Company will cause the Restricted Shares to be issued in the Grantee’s name either by
book-entry registration or issuance of a stock certificate or certificates.

          (b) While the Restricted Shares remain forfeitable, the Company will cause an appropriate
stop-transfer order to be issued and to remain in effect with respect to the Restricted Shares. As
soon as practicable following the time that any Restricted Share becomes nonforfeitable (and
provided that appropriate arrangements have been made with the Company for the withholding or
payment of any taxes that may be due with respect to such share), the Company will cause that
stop-transfer order to be removed. The Company may also condition delivery of certificates for
Restricted Shares upon receipt from the Grantee of any undertakings, customarily requested of other
similarly situated recipients of restricted stock awards from the Company, that it may promptly
determine are appropriate to facilitate compliance with federal and state securities laws.

          (c) If any certificate is issued in respect of Restricted Shares, that certificate will be
legended and held in escrow by the Company or an agent of the Company. In addition, the Grantee
may be required to execute and deliver to the Company a stock power with respect to those
Restricted Shares. At such time as those Restricted Shares become nonforfeitable, the Company will
cause a new certificate to be issued without that portion of the legend referencing the previously
applicable forfeiture conditions and will promptly cause that new certificate to be delivered to
the Grantee (provided that appropriate arrangements have been made with the Company for the
withholding or payment of any taxes that may be due with respect to such shares).

     4. Substitute Property. If, while any of the Restricted Shares remain subject to
forfeiture, there occurs a merger, reclassification, recapitalization, stock split, stock dividend
or other similar event or transaction resulting in new, substituted or additional securities being
issued or delivered to the Grantee by reason of the Grantee’s ownership of the Restricted Shares,
such securities will constitute “Restricted Shares” for all purposes of this Agreement and
any certificate issued to evidence such securities will immediately be deposited with the secretary
of the Company (or his or her designee) and subject to the escrow described in Section 3, above.

     5. Rights of Grantee During Restricted Period. The Grantee will have the right to
vote the Restricted Shares and to receive dividends and distributions with respect to the
Restricted Shares; provided, however, that any cash dividends or distributions paid in respect of
the Restricted Shares while those shares remain subject to forfeiture will be withheld by the
Company and will be delivered to the

-3-

 

Grantee (without interest and net of any required tax withholding) only if and when the
Restricted Shares giving rise to such dividends or distributions become vested and non-forfeitable.

     6. Securities Laws. The Board may from time to time impose any conditions on the
Restricted Shares as it deems necessary or advisable to ensure that the Restricted Shares are
issued and sold in compliance with the requirements of any stock exchange or quotation system upon
which the shares are then listed or quoted, the Securities Act of 1933 and all other applicable
laws.

     7. Tax Consequences.

          (a) The Grantee acknowledges that the Company has not advised the Grantee regarding the
Grantee’s income tax liability in connection with the grant or vesting of the Restricted Shares.
The Grantee has had the opportunity to review with his or her own tax advisors the federal, state
and local tax consequences of the transactions contemplated by this Agreement. The Grantee is
relying solely on such advisors and not on any statements or representations of the Company or any
of its agents. The Grantee understands that the Grantee (and not the Company) shall be responsible
for the Grantee’s own tax liability that may arise as a result of the transactions contemplated by
this Agreement.

          (b) If the Grantee makes an election under Section 83(b) of the Code with respect to the grant
of the Restricted Shares, the Grantee agrees to notify the Company in writing on the day of such
election. The amount includible in the Grantee’s income as a result of that election will be
subject to tax withholding. The Grantee will be required to remit to the Company in cash, or make
other arrangements reasonably satisfactory to the Company for the satisfaction of such tax
withholding amount; failure to do so within five business days of making the Section 83(b) election
will result in forfeiture of all the Restricted Shares.

     8. The Plan. Although this Award of Restricted Stock is not granted under the Plan,
the terms of the Plan have been incorporated herein by reference. Accordingly, the Grantee agrees
to be bound by all of the terms and conditions of the Plan, as such Plan may be amended from time
to time in accordance with the terms thereof; provided, that no amendment to the Plan after the
date hereof which adversely affects the Grantee’s rights hereunder or interest in the Restricted
Shares will be binding on the Grantee without the Grantee’s prior written agreement (other than any
such amendment which is required under applicable law or rules of the national market system on
which the Company’s securities are traded). This Award of Restricted Stock will be administered by
the Board or its designated Committee, who will have the same authority with respect to this Award
of Restricted Stock as described in Section 4 of the Plan. A copy of the Plan in its present form
has been provided to the Grantee on or prior to the date hereof. All questions regarding the
interpretation of the terms of this Award of Restricted Stock, including all questions regarding
the application and interpretation of Plan provisions incorporated herein, will be determined by
the Board or its designated Committee, whose determination will be final, binding and conclusive.

     9. Covenant Not to Solicit.

          (a) While the Grantee is in service to the Company (or any of its subsidiaries or Affiliates),
and for one year following cessation of the Grantee’s service to the Company (or any of its
subsidiaries or Affiliates) for any reason, the Grantee shall not, directly or indirectly:

               i. cause, solicit, induce or encourage, or attempt to cause, solicit, induce or
encourage, any actual or prospective customer, supplier or independent contractor of the Company or
any of its subsidiaries or Affiliates (including any existing or former customer, supplier or
independent contractor of the Company or any of its subsidiaries or Affiliates and any Person that
becomes a

-4-

 

customer, supplier or independent contractor of the Company or any of its subsidiaries or
Affiliates on or after the date of termination of the Grantee’s service to the Company or any of
its subsidiaries or Affiliates), or any other Person who has a business relationship with the
Company or any of its subsidiaries or Affiliates, to terminate, modify or not establish any such
actual or prospective relationship;

               ii. cause, solicit, induce or encourage, or attempt to cause, solicit, induce or
encourage, any employee or other Person providing service to the Company or any of its subsidiaries
or Affiliates, or any employee or other Person providing service to the Company or any of its
subsidiaries or Affiliates during the immediately preceding rolling twelve (12) month period, to
leave such employment or service, or hire, employ or otherwise engage any such Person; provided
that the foregoing shall not prohibit any general solicitation or advertising activities not
targeted at any such Person.

          (b) Acknowledgements. The Grantee acknowledges that the Restricted Shares would not
be granted in the absence of the Grantee’s agreement to this Section 9.

          (c) Specific Enforcement. The Grantee acknowledges that any breach by the Grantee,
willfully or otherwise, of this Section 9 will cause continuing and irreparable injury to the
Company and its subsidiaries and Affiliates for which monetary damages would not be an adequate
remedy. The Grantee shall not, in any action or proceeding to enforce any of the provisions of
this Section 9, assert the claim or defense that such an adequate remedy at law exists. In the
event of any such breach by the Grantee of any of the provisions of this Section 9, the Company
shall be entitled to injunctive or other similar equitable relief in any court, without any
requirement that a bond or other security be posted, and this Agreement shall not in any way limit
remedies of law or in equity otherwise available to the Company.

          (d) Accounting. If the Grantee breaches any of the provisions of this Section 9, the
Company will have the right and remedy to require the Grantee to account for and pay over to the
Company all compensation, profits, monies, accruals, increments or other benefits derived or
received by the Grantee as the result of such breach. This right and remedy will be in addition
to, and not in lieu of, any other rights and remedies available to the Company under law or in
equity.

          (e) Enforceability in Multiple Jurisdictions. If any court holds the provisions of
this Section 9 unenforceable, it is the intention of the parties hereto that such determination not
bar, or in any way affect, the right of the Company to the relief herein provided in the courts of
any other jurisdiction.

          (f) Disclosure and Extension of Restrictive Covenants. The Grantee shall promptly
disclose the existence and terms of this Section 9 to any party that the Grantee may be employed by
or provide services to while the restrictions of this Section 9 remain in effect. If the Grantee
breaches this Agreement in any respect, the restrictions contained in that section will be extended
for a period equal to the period that the Grantee was in breach.

          (g) Survival. The obligations contained in this Section 9 shall survive the cessation
of any relationship between the Grantee and the Company or its subsidiaries or Affiliates.

          (h) Successors and Assigns. The Company may assign its rights under Section 9 of this
Agreement to any successor to all or substantially all of its assets and business by means of
liquidation, dissolution, merger, consolidation, transfer of assets, or otherwise. The duties and
obligations of the Grantee hereunder are personal to the Grantee and may not be assigned by the
Grantee.

     10. Consent to Electronic Delivery. The Grantee hereby authorizes the Company to
deliver electronically any prospectuses or other documentation related to this Agreement, the Plan
and any other

-5-

 

compensation or benefit plan or arrangement in effect from time to time (including, without
limitation, reports, proxy statements or other documents that are required to be delivered to
participants in such plans or arrangements pursuant to federal or state laws, rules or
regulations). For this purpose, electronic delivery will include, without limitation, delivery by
means of e-mail or e-mail notification that such documentation is available on the Company’s
intranet site. Upon written request, the Company will provide to the Grantee a paper copy of any
document also delivered to the Grantee electronically. The authorization described in this
paragraph may be revoked by the Grantee at any time by written notice to the Company.

     11. Entire Agreement. This Agreement, including the terms incorporated herein by
reference, represents the entire agreement between the parties hereto relating to the subject
matter hereof, and merges and supersedes all prior and contemporaneous discussions, agreements and
understandings of every nature relating to the subject matter hereof. Notwithstanding anything to
the contrary, this Agreement will not supersede any other restrictive covenant agreement between
the Grantee and the Company or any of its Affiliates and the Grantee shall be bound both by the
restrictions set forth in such other restrictive covenants agreements and the restrictions set
forth in this Agreement.

     12. Severability. Whenever possible, each provision and term of this Agreement shall
be interpreted in a manner to be effective and valid, but if any provision or term of this
Agreement is held to be prohibited or invalid, then such provision or term will be ineffective only
to the extent of such prohibition or invalidity, without invalidating or affecting in any manner
whatsoever the remainder of such provision or term or the remaining provisions or terms of this
Agreement. If any of the covenants set forth in this Agreement are held to be unreasonable,
arbitrary or against public policy, such covenants will be considered divisible with respect to
scope, time and geographic area, and in such lesser scope, time and geographic area, will be
effective, binding and enforceable against the Grantee.

     13. Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware, without regard to the principles of conflicts of laws. Any
legal proceeding arising out of or relating to this Agreement will be instituted in a state or
federal court in the State of Delaware, and the Grantee and the Company hereby consent to the
personal and exclusive jurisdiction of such court(s) and hereby waive any objection(s) that they
may have to personal jurisdiction, the laying of venue of any such proceeding and any claim or
defense of inconvenient forum.

     14. Amendment. This Agreement may only be amended by a writing signed by each of the
parties hereto.

     15. Execution. This Agreement may be executed, including execution by facsimile
signature, in one or more counterparts, each of which will be deemed an original, and all of which
together shall be deemed to be one and the same instrument.

     16. Clawback.

          (a) Grantee’s Conduct. Notwithstanding anything to the contrary contained herein, if
the Company as a result of misconduct or fraud is required to prepare a financial restatement due
to the material noncompliance of the Company with any financial reporting requirement under the
securities laws, where the Grantee (i) engaged in fraud resulting in such financial restatement, or
(ii) knowingly or through gross negligence engaged in misconduct resulting in such financial
restatement, the Grantee shall forfeit any or all of the Restricted Shares, whether or not vested,
then held by the Grantee and repay to the Company an amount in cash equal to all or any portion of
the sales proceeds received by the Grantee in connection with the sale or other disposition of any
such Restricted Shares during the three-year period preceding the date on which the Company first
determines that it must prepare the financial restatement

-6-

 

(or, if no proceeds were received by the Grantee in any such disposition, an amount equal to
the aggregate fair market value of the Restricted Shares so disposed of, determined as of the date
of such disposition). For the avoidance of doubt, the Grantee’s failure to have personal knowledge
of the conduct of any other individual that contributed to a financial restatement shall not, in
and of itself, be sufficient to trigger this provision.

          (b) Conduct of Others or Errors. Notwithstanding anything to the contrary contained
herein, the Grantee shall repay the Company any amount in excess of what the Grantee should have
received under the terms of the Award for any reason (including without limitation by reason of a
financial restatement, mistake in calculation or other administrative error) with respect to any
sale or other disposition of any Restricted Shares during the three-year period preceding the date
on which the Company first determines that it must prepare the financial restatement or otherwise
first discovers the mistake or error and promptly notifies the Grantee.

          (c) Compliance. The Grantee will agree to revise this Section 16 to the extent
necessary for the Company to comply with any regulatory guidance promulgated under Section 954 of
the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.

[signature page follows]

-7-

 

     IN WITNESS WHEREOF, the Company’s duly authorized representative and the Grantee have each
executed this Restricted Stock Award Agreement on the respective date below indicated.

	 	 	 	 	 	 	 

	 	 	MEDQUIST HOLDINGS INC.	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 

	 	 
	 	/s/ Tony James	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	
By

Name: Anthony James

Title: Chief Financial Officer

Date: August 18, 2011	 	 
	 
	 	 	 	 	 	 
	 	 	GRANTEE	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ Juergen Fritsch	 	 
	 	 	 	 	 
	 	 	Signature

Name: Juergen Fritsch

Date: 7-12-2011	 	 

Signature Page to Restricted Award Agreementexv10w60

Exhibit 10.60

RESTRICTIVE COVENANT AGREEMENT

          THIS RESTRICTIVE COVENANT AGREEMENT (the “Agreement”), effective as of August 18, 2011,
between Juergen Fritsch (“Shareholder”) and MedQuist Holdings Inc., a Delaware corporation (the
“Company”).

          WHEREAS, pursuant to that certain Agreement and Plan of Merger and Reorganization, dated July
11, 2011, by and among the Company, Multimodal Technologies, Inc., a Pennsylvania corporation
(“Multimodal”) and certain other parties thereto (the “Merger Agreement”), the Company will acquire
Multimodal (the “Transaction”), and all of the issued and outstanding capital stock of Multimodal
shall be converted into the right to receive the consideration set forth in the Merger Agreement;

          WHEREAS, in connection with the Transaction, Shareholder will receive significant money and
other property in exchange for Shareholder’s equity securities of Multimodal;

          WHEREAS, Shareholder acknowledges that the Company would not enter into the Merger Agreement
or complete the Transaction unless Shareholder agrees to be bound by the restrictive covenants set
forth in this Agreement and that, accordingly, Shareholder is entering into this Agreement to
induce the Company to enter into the Merger Agreement and consummate the Transaction.

          NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and promises
contained herein, and intending to be bound hereby, the parties agree as follows:

     1. Definitions. Capitalized terms used herein that are not defined where used shall
have the meanings ascribed to them below:

          1.1. “Affiliate” shall have the meaning set forth in the Merger Agreement.

          1.2. “Closing Date” shall have the meaning set forth in the Merger Agreement.

          1.3. “Company Group” means, collectively and individually, the Company and each of its
Subsidiaries.

          1.4. “Competing Business” means any Person involved, anywhere in the world, in, for the
purpose of creating patient records or supplementing existing patient records, selling or reselling
technology products for use in the transcription of speech or in providing natural language
processing of text or in selling software-based solutions designed to provide means to capture,
interpret or analyze clinical data using speech recognition, speech understanding or natural
language processing capabilities.

          1.5. “Person” means any individual, firm, corporation, partnership, limited liability company,
trust, joint venture, association, governmental entity, unincorporated entity or other entity.

 

 

          1.6. “Restricted Period” means the period beginning on the Closing Date and ending on the
fifth (5th) anniversary of the Closing Date.

     2. Restrictive Covenants. To induce the Company to enter into the Merger Agreement
and to consummate the Transaction, and in recognition of the substantial money and property which
Shareholder shall receive in exchange for his equity ownership interests in Multimodal upon
consummation of the Transaction, Shareholder shall be bound by the provisions of this Section 2
(the “Restrictive Covenants”).

          2.1. Covenant Not To Compete. During the Restricted Period, Shareholder shall not,
directly or indirectly, own, manage, join, operate, participate in or otherwise be engaged in any
Competing Business. For purposes of this Section, (i) “participate” includes any direct or
indirect interest in any enterprise, whether as a stockholder, partner, joint venturer or otherwise
or rendering any direct or indirect service or assistance (including as a creditor for money
borrowed) to any Person, and (ii) ownership of voting securities of an entity whose securities are
publicly traded on a recognized securities exchange or quotation system not, in the aggregate, in
excess of two percent (2%) of such voting securities shall not be considered to be owning,
managing, joining, operating, participating in or otherwise being engaged in any Competing
Business. Shareholder acknowledges that this covenant is reasonably designed to protect the
Company’s substantial investment in Multimodal and is reasonable with respect to its duration,
geographical area and scope. For the avoidance of doubt, any employee, manager or officer of any
member of the Company Group shall not be considered to be participating in any Competing Business
in violation of this Section 2.1 in carrying out his or her activities on behalf of the Company
Group within his or her authority.

          2.2. Covenant Not To Solicit. During the Restricted Period, Shareholder shall not,
directly or indirectly:

               2.2.1. cause, solicit, induce or encourage, or attempt to cause, solicit, induce or encourage,
any actual or prospective customer, supplier or independent contractor of any member of the Company
Group (including any existing or former customer, supplier or independent contractor of any member
of the Company Group and any Person that becomes a customer, supplier or independent contractor of
any member of the Company Group on or after the Closing Date), or any other Person who has a
business relationship with any member of the Company Group, to terminate, modify or not establish
any such actual or prospective relationship;

               2.2.2. (a) cause, solicit, induce or encourage, or attempt to cause, solicit, induce or
encourage, any employee or other Person providing service to any member of the Company Group to
leave such employment or service, or (b) hire, employ or otherwise engage any employee, former
employee or other Person that provided service to any member of the Company Group during the
immediately preceding twelve (12) month period; provided that the foregoing shall not prohibit any
general solicitation or advertising activities not targeted at any such Person.

     3. Acknowledgements. Shareholder acknowledges that the restrictions on Shareholder’s
activities under this Agreement constitute a material inducement to the

 

 

consummation of the Transaction, and Shareholder further acknowledges, stipulates and agrees
that a breach of any of the obligations and agreements set forth in this Agreement will result in
irreparable harm and continuing damage to the Company Group for which there will be no adequate
remedy at law and further agrees that in the event of any breach of said obligations and
agreements, the Company and its successors and assigns will be entitled to injunctive relief and to
such other relief as is proper under the circumstances.

4. Remedies and Enforcement Upon Breach.

          4.1. Specific Enforcement. Shareholder acknowledges that any breach by Shareholder,
willfully or otherwise, of the Restrictive Covenants will cause continuing and irreparable injury
to the Company Group for which monetary damages would not be an adequate remedy. Shareholder shall
not, in any action or proceeding to enforce any of the provisions of this Agreement, assert the
claim or defense that such an adequate remedy at law exists. In the event of any such breach by
Shareholder of any of the Restrictive Covenants, the Company shall be entitled to injunctive or
other similar equitable relief in any court, without any requirement that a bond or other security
be posted, and this Agreement shall not in any way limit remedies of law or in equity otherwise
available to the Company.

          4.2. Judicial Modification. If any court determines that any of the Restrictive
Covenants, or any part thereof, is unenforceable because of the duration or geographical scope of
such provision, such court shall have the power to modify such provision and, in its modified form,
such provision shall then be enforceable.

          4.3. Accounting. If Shareholder breaches any of the Restrictive Covenants, the
Company will have the right and remedy to require Shareholder to account for and pay over to the
Company all compensation, profits, monies, accruals, increments or other benefits derived or
received by Shareholder as the result of such breach. This right and remedy will be in addition
to, and not in lieu of, any other rights and remedies available to the Company under law or in
equity.

          4.4. Enforceability. If any court holds the Restrictive Covenants unenforceable by
reason of their breadth or scope or otherwise, it is the intention of the parties hereto that such
determination not bar or in any way affect the right of the Company to the relief provided above in
the courts of any other jurisdiction within the breadth or scope of such Restrictive Covenants.

          4.5. Disclosure of Restrictive Covenants. Shareholder shall promptly disclose the
existence and terms of the Restrictive Covenants to any Person that Shareholder may be employed by
or provide services to during the Restricted Period.

          4.6. Extension of Restricted Period. If Shareholder breaches this Agreement in any
respect, the restrictions contained in that section will be extended for a period equal to the
period that Shareholder was in breach.

5. Miscellaneous.

          5.1. Other Agreements. Shareholder represents and warrants to the Company that there
are no restrictions, agreements or understandings whatsoever to which Shareholder is a

 

 

party that would prevent or make unlawful Shareholder’s execution of this Agreement, that
would be inconsistent or in conflict with this Agreement or Shareholder’s obligations hereunder, or
that would otherwise prevent, limit or impair the performance by Shareholder of Shareholder’s
duties under this Agreement.

          5.2. Successors and Assigns. The Company may assign this Agreement to any successor
to all or substantially all of its assets and business by means of liquidation, dissolution,
merger, consolidation, transfer of assets, or otherwise. The duties and obligations of Shareholder
hereunder are personal to Shareholder and may not be assigned by Shareholder.

          5.3. Governing Law and Forum. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York, without regard to the principles of conflicts of
laws. Any legal proceeding arising out of or relating to this Agreement will be instituted in a
state or federal court in the State of New York, and Shareholder and the Company hereby consent to
the personal and exclusive jurisdiction of such court(s) and hereby waive any objection(s) that
they may have to personal jurisdiction, the laying of venue of any such proceeding and any claim or
defense of inconvenient forum.

          5.4. Waivers. The waiver by either party of any right hereunder or of any breach by
the other party will not be deemed a waiver of any other right hereunder or of any other breach by
the other party. No waiver will be deemed to have occurred unless set forth in a writing. No
waiver will constitute a continuing waiver unless specifically stated, and any waiver will operate
only as to the specific term or condition waived.

          5.5. Severability. Whenever possible, each provision and term of this Agreement shall
be interpreted in a manner to be effective and valid, but if any provision or term of this
Agreement is held to be prohibited or invalid, then such provision or term will be ineffective only
to the extent of such prohibition or invalidity, without invalidating or affecting in any manner
whatsoever the remainder of such provision or term or the remaining provisions or terms of this
Agreement. If any of the covenants set forth in this Agreement are held to be unreasonable,
arbitrary or against public policy, such covenants will be considered divisible with respect to
scope, time and geographic area, and in such lesser scope, time and geographic area, will be
effective, binding and enforceable against Shareholder.

          5.6. Survival. The obligations contained in this Agreement shall survive the
termination of any relationship between Shareholder and the Company Group.

          5.7. Entire Agreement; Amendments. This Agreement contains the entire agreement and
understanding of the parties hereto relating to the subject matter hereof, and merges and
supersedes all prior and contemporaneous discussions, agreements and understandings of every nature
relating to the subject matter, other than any employment agreement between any member of the
Company Group and Shareholder and that certain Restrictive Stock Award Agreement dated on or about
the date hereof between the Shareholder and the Company. This Agreement may not be changed or
modified, except by an agreement in writing signed by each of the parties hereto.

 

 

          5.8. Section Headings. The headings of sections and paragraphs of this Agreement are
inserted for convenience only and will not affect the meaning or construction of any provision of
this Agreement.

          5.9. Counterparts; Facsimile. This Agreement may be executed in multiple counterparts
(including by facsimile signature), each of which will be deemed to be an original, but all of
which together will constitute but one and the same instrument.

[This space left blank intentionally; signature page follows]

 

 

          IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer, and Shareholder has executed this Agreement, in each case as of the date
indicated below.

	 	 	 	 	 
	 	MEDQUIST HOLDINGS INC.

 	 
	 	By:  	/s/ Tony James
 	 
	 	 	Title:     Chief Financial Officer         	 
	 	 	Date: August 18, 2011	 
	 
	 	SHAREHOLDER

 	 
	 	/s/ Juergen Fritsch
 	 
	 	Date:   7-12-2011

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]